Earnings Alerts

Givaudan (GIVN) Earnings: First-Half Sales Beat Estimates at CHF 3.74 Billion

  • Strong Sales Performance: Givaudan’s first-half sales reached CHF 3.74 billion, exceeding the estimated CHF 3.69 billion.
  • Growth Achievement: Like-for-like sales growth was 12.5%, slightly below the 12.6% estimate.
  • Net Debt: The company’s net debt amounted to CHF 4.72 billion.
  • Analyst Recommendations: Givaudan holds 6 buy ratings, 16 hold ratings, and 4 sell ratings.

A look at Givaudan Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth4
Resilience2
Momentum5
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Investors looking at Givaudan SA for the long term can find optimism in the company’s Smartkarma Smart Scores. With a high Growth score of 4 and Momentum score of 5, Givaudan appears to have strong potential for future expansion and market performance. This suggests that the company is well-positioned to capitalize on emerging trends and grow its market presence over time.

While Givaudan scores lower in Value and Resilience at 2, and Dividend at 3, indicating some areas of weakness, the overall high scores in Growth and Momentum bode well for its long-term outlook. With its global operations in manufacturing fragrances and flavors, Givaudan’s ability to innovate and adapt to changing consumer preferences could drive sustained growth in the future.

### Givaudan SA manufactures and markets fragrances and flavors from natural and synthetic ingredients. The Company sells its products to manufacturers of perfumes, beverages, prepared foods, and consumer goods. Givaudan operates worldwide. ###


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars